Advertisement

Effect of periodontal therapy on glycemic control and circulating TNF-α in type 2 diabetic patients

  • Manoj KumarEmail author
  • Prasanta Bandyopadhyay
  • Lora Mishra
  • Satadal Das
  • Prabir Kumar Kundu
  • Surajit Mistry
Original Article

Abstract

Studies suggest that elevated circulating tumour necrosis factor- α (TNF- α) may contribute to insulin resistance in patients with type 2 diabetes. The source of plasma TNF has been thought to be adipocytes associated with obesity, but inflammation and infection result in TNF- α production as well. The present study was a randomized controlled clinical trial to evaluate the role of periodontal treatment in glycemic control and its relationship with the inflammatory marker TNF-α in type 2 diabetic subjects with chronic generalized periodontitis. In total, 30 patients were enrolled in the study. The selected patients were randomly assigned into two groups (group A and B) comprising of fifteen patients each. Patients who refused periodontal treatment were automatically placed in the control group; others were randomly assigned to either treatment or control group. Group A (Treatment group) which received treatment with full mouth scaling and root planing followed by systemic Doxycycline (100 mg daily for 14 days) and Group B (Control group) which received no treatment. The plaque index, gingival index, probing depth, clinical attachment loss, HbA1c value, and circulating TNF- α concentrations were measured at baseline and three months after the non-surgical periodontal therapy in both the treatment and control groups. All periodontal parameters, serum TNF- α levels and HbA1c levels were significantly decreased three months after the nonsurgical periodontal therapy compared to the baseline values in the treatment group where as there was no significant change in the control group. The study results indicated that periodontal treatment could be undertaken along with the standard measures for the diabetic patient care and prevention, and control of periodontal disease must be considered as an integral part of diabetes control.

Keywords

Periodontal therapy TNF-α HbA1c Type 2 diabetes mellitus 

Notes

Source of funding

None

Conflicts of interest

None

References

  1. 1.
    Diabetes and periodontal diseases [position paper]. J Periodontol 2000; 71:664–678.Google Scholar
  2. 2.
    Lalla E, Lamster IB, Drury S, Fu C, Schmidt AM. Hyperglycemia glycoxidation and receptor for advanced glycation end products: potential mechanisms underlying diabetic complications, including diabetes – associated periodontitis. Periodontology 2000. 2000;23:50–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993;16(1):329–34.PubMedCrossRefGoogle Scholar
  4. 4.
    Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol. 2007;34(10):835–43.PubMedCrossRefGoogle Scholar
  5. 5.
    Taylor GW. The effects of periodontal treatment on diabetes. J Am Dent Assoc. 2003;134 Spec No:41S–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Nishimura F, Murayama Y. Periodontal inflammation and insulin resistance-lessons from obesity. J Dent Res. 2001;80(8):1690–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Iacopino AM. Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol. 2001;6(1):125–37.PubMedCrossRefGoogle Scholar
  8. 8.
    Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4(1):1–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Promsudthi A, Pimapansri S, Deerochanawong C, Kanchanavasita W. The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects. Oral Dis. 2005;11(5):293–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Silness J, Loe H. Periodontal disease in pregnancy (II). Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121–35.PubMedCrossRefGoogle Scholar
  11. 11.
    Loe H, Silness J. Periodontal disease in pregnancy (I). Prevalence and severity. Acta Odontol Scand. 1963;21:533–51.PubMedCrossRefGoogle Scholar
  12. 12.
    Shlossman M, Knowler WC, Pettit DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc. 1990;121(4):532–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Grossi SG, Skrepcinski FB, Decaro T, Robertson DC, Ho AW, Dunford RG, et al. Treatment of periodontal disease in diabetes reduces glycated haemoglobin. J Periodontol. 1997;68(8):713–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Kiran M, Arpak N, Unsal E, Erdogan MF. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol. 2005;32(3):266–72.PubMedCrossRefGoogle Scholar
  15. 15.
    Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol. 2001;72(6):774–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Rodrigues DC, Taba MJ, Novaes AB, Souza SL, Grisi MF. Effect of non surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol. 2003;74(9):1361–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Dag A, Fırat ET, Arıkan S, Kadiroglu AK, Kaplan A. The effect of periodontal therapy on serum TNF-α and HbA1c levels in type 2 diabetic patients. Aust Dent J. 2009;54(1):17–22.PubMedCrossRefGoogle Scholar
  18. 18.
    Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S. Healing response to nonsurgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological and immunologic results. J Clin Periodontol. 1998;25(2):112–24.PubMedCrossRefGoogle Scholar
  19. 19.
    Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol. 1996;23(2):92–100.PubMedCrossRefGoogle Scholar
  20. 20.
    O’Connell PA, Taba M, Nomizo A, Foss Freitas MC, Suaid FA, Uyemura SA, et al. Effects of periodontal therapy on Glycemic control and inflammatory markers. J Periodontol. 2008;79(5):774–83.PubMedCrossRefGoogle Scholar
  21. 21.
    Lim LP, Tay FB, Sum CF, Thai AC. Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus. J Clin Periodontol. 2007;34(2):118–23.PubMedCrossRefGoogle Scholar
  22. 22.
    Talbert J, Elter J, Jared HL, Offenbacher S, Southerland J, Wilder RS. The effect of periodontal therapy on TNF-α, IL-6 and metabolic control in type 2 diabetics. J Dent Hyg. 2006;80(2):1–16.Google Scholar
  23. 23.
    Mealey BL. Periodontal disease and diabetes: a two- way street. J Am Dent Assoc. 2006;137(Suppl):26S–31.PubMedCrossRefGoogle Scholar
  24. 24.
    Yang PS, Wang Y, Oi XM, Ren JM, Ge SH. The effect of initial periodontal therapy on circulating TNF-α and HbA1c in type 2 diabetes patients with periodontitis. Zhongua Kou Qiang Yi Xue Za Zhi. 2003;38(5):364–6.Google Scholar
  25. 25.
    Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S, et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol. 2003;74(8):1231–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Kardeşler L, Buduneli N, Cetinkalp S, Kinane DF. Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol. 2010;81(1):24–33.PubMedCrossRefGoogle Scholar
  27. 27.
    Yamazaki K, Honda T, Oda T, Ueki-Maruyama K, Nakajima T, Yoshie H, et al. Effect of periodontal therapy on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res. 2005;40(1):53–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Engebretson S, Chertog R, Nichols A, Hey-Hadavi J, Celenti R, Grbic J. Plasma levels of tumour necrosis factor-a in patients with chronic periodontitis and type 2 diabetes. J Clin Periodontol. 2007;34(1):18–24.PubMedCrossRefGoogle Scholar
  29. 29.
    Bretz WA, Weyant RJ, Corby PM, Ren D, Weissfeld L, Kritchevsky SB, et al. Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population. J Am Geriatr Soc. 2005;53(9):1532–7.PubMedCrossRefGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2015

Authors and Affiliations

  • Manoj Kumar
    • 1
    Email author
  • Prasanta Bandyopadhyay
    • 2
  • Lora Mishra
    • 3
  • Satadal Das
    • 4
  • Prabir Kumar Kundu
    • 5
  • Surajit Mistry
    • 2
  1. 1.Department of Periodontics and ImplantologyInstitute of Dental Sciences, Siksha ‘O’ Anusandhan UniversityBhubaneswarIndia
  2. 2.Department of Periodontics and ImplantologyDr. R. Ahmed Dental College and HospitalKolkataIndia
  3. 3.Department of Conservative Dentistry and EndodonticsInstitute of Dental Sciences, Siksha ‘O’ Anusandhan UniversityBhubaneswarIndia
  4. 4.Department of Pathology and MicrobiologyD.N.De Homeopathic Medical College and HospitalKolkataIndia
  5. 5.Department of Endocrine, Nutrition and Metabolic DiseasesCalcutta School of Tropical MedicineKolkataIndia

Personalised recommendations